Daniel Caldeira i wsp – Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis BMJ 2012;345:e4260 (dostępny pełen tekst)
Conclusions: The best evidence available points towards a putative protective role of ACE inhibitors but not ARBs in risk of pneumonia. Patient populations that may benefit most are those with previous stroke and Asian patients. ACE inhibitors were also associated with a decrease in pneumonia related mortality, but the data lacked strength.
Opracowane na podstawie: BMJ 2012;345:e4260 / 11 lipca 2012